-
Integra LifeSciences names three new executives to key roles
-
BTI on Integra LifeSciences (IART): 'The Hits Keep Coming'
-
Integra LifeSciences (IART) PT Lowered to $11 at Citi
-
Integra LifeSciences (IART) Tops Q3 EPS by 11c, provides guidance
-
Citizens JMP Reiterates Market Outperform Rating on Integra LifeSciences (IART)
-
Integra LifeSciences (IART) Tops Q2 EPS by 1c ; Offers Guidance
-
Organogenesis Holding (ORGO), Smith & Nephew (SNN) & Integra LifeSciences (IART) Also Fall on CMS Publication
-
Integra LifeSciences (IART) PT Lowered to $25 at Citizens JMP
-
Integra LifeSciences (IART) Misses Q1 EPS by 15c; offers guidance
-
Argus Upgrades Integra LifeSciences (IART) to Buy, 'well positioned for a turnaround'
-
Notice to Long-term Integra Lifesciences Holdings Corporation (IART) Shareholders: Grabar Law Investigates Claims on Your Behalf
-
INTEGRA STOCKHOLDER NOTICE: Kaskela Law LLC Announces Investigation of Integra LifeSciences Holdings Corp. (IART) and Encourages Long-Term IART Investors to Contact the Firm
-
Citizens JMP Reiterates Market Outperform Rating on Integra LifeSciences (IART)
-
Notice to Long-Term Integra Lifesciences Holdings Corporation (IART) Shareholders: Grabar Law Investigates Claims on Your Behalf
-
Integra LifeSciences (IART) subsidiary receives warning letter from FDA
-
Notice to Long-Term Integra Lifesciences Holdings Corporation (IART) Shareholders
-
Integra LifeSciences (IART) Tops Q3 EPS by 2c; offers guidance
-
Integra LifeSciences (IART) PT Raised to $22 at Citi
-
Integra LifeSciences (IART) Appoints Mojdeh Poul as CEO
-
BTIG Upgrades Integra LifeSciences (IART) to Neutral
-
Integra LifeSciences (IART) PT Lowered to $26 at Truist Securities
-
Citi Downgrades Integra LifeSciences (IART) to Sell
-
BTIG Downgrades Integra LifeSciences (IART) to Sell
-
Integra LifeSciences (IART) call put ratio 3.1 calls to 1 put as share price down 18.7%
-
Integra LifeSciences (IART) Tops Q2 EPS by 1c
-
Integra LifeSciences (IART) PT Raised to $32 at Truist Securities
-
Citi Reiterates Neutral Rating on Integra LifeSciences (IART)

